2020
DOI: 10.4103/joacp.joacp_70_20
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study of hemodynamic effects of intrathecal bupivacaine with butorphanol in cardiac and non-cardiac patients

Abstract: Background and Aims: The synergism between intrathecal opioids and low dose local anesthetics makes it possible to achieve reliable spinal anesthesia (SA) with minimal hypotension. The study objective was to compare the hemodynamic effects of reduced dose of 0.5% intrathecal bupivacaine (2mL) with 25 μg butorphanol in cardiac vs non-cardiac patients. Material and Methods: We included sixty patients aged 30-80 years, undergoing infraumbilical surgeries in the study and c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…When administered intrathecally, butorphanol tartrate is used as an adjuvant in combination with local anaesthetics to provide satisfactory analgesia, reduce the adverse effects of local anaesthetic drugs, and prolong the duration of postoperative analgesia [24] . Intrathecal local anaesthetics interfere with afferent and efferent sensory and motor impulse conduction by inhibiting voltage-gated sodium channels in the spinal cord, whereas intrathecal injection of butorphanol activates opioid receptors in the dorsal grey matter of the spinal cord and blocks calcium channels to regulate the function of afferent pain fibres, producing a synergistic effect when the two are used in combination, i.e., local anaesthetic drugs blocking the Na+ channels and butorphanol blocking Ca+ channels, which improves both the analgesic quality, as well as reducing sympathetic inhibition and obtaining more stable haemodynamics, which is very beneficial for cardiac patients undergoing non-cardiac surgery [25,26] . At the same time, intrathecal injection of Butorphanol combined with local anaesthetic drugs can also reduce the intensity of motor block, which is conducive to the early walking of patients, and can reduce the occurrence of itching and other complications [27] .…”
Section: Multimodal Analgesic Programme With Bupropion Tartratementioning
confidence: 99%
“…When administered intrathecally, butorphanol tartrate is used as an adjuvant in combination with local anaesthetics to provide satisfactory analgesia, reduce the adverse effects of local anaesthetic drugs, and prolong the duration of postoperative analgesia [24] . Intrathecal local anaesthetics interfere with afferent and efferent sensory and motor impulse conduction by inhibiting voltage-gated sodium channels in the spinal cord, whereas intrathecal injection of butorphanol activates opioid receptors in the dorsal grey matter of the spinal cord and blocks calcium channels to regulate the function of afferent pain fibres, producing a synergistic effect when the two are used in combination, i.e., local anaesthetic drugs blocking the Na+ channels and butorphanol blocking Ca+ channels, which improves both the analgesic quality, as well as reducing sympathetic inhibition and obtaining more stable haemodynamics, which is very beneficial for cardiac patients undergoing non-cardiac surgery [25,26] . At the same time, intrathecal injection of Butorphanol combined with local anaesthetic drugs can also reduce the intensity of motor block, which is conducive to the early walking of patients, and can reduce the occurrence of itching and other complications [27] .…”
Section: Multimodal Analgesic Programme With Bupropion Tartratementioning
confidence: 99%